Physician

Matthew Benz, MD

According to 2025 Medicare claims, Matthew Benz, MD (NPI: 1689771545) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1902975352; TIN: 742109903) and primary practice location at 77429-4699.

Benz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,210 traditional Medicare patients, billed 34,260 HCPCS/CPT codes, and received $6,068,934 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 524 prescription claims across 167 beneficiaries totaling $35,120 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 11 records totaling $265. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $22,718 to $35,120. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0M$6.1M2015 Medicare payment: $4,350,251 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,301,099 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,491,875 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,782,679 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,837,872 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,949,568 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,784,161 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,202,454 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,702,996 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $6,068,934 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,14518,267$4,350,251
20161,05318,594$4,301,099
20171,04219,861$4,491,875
20181,04621,570$4,782,679
20191,12621,871$4,837,872
20201,07321,949$4,949,568
20211,09120,622$4,784,161
20221,24518,215$5,202,454
20231,18423,250$5,702,996
20241,21034,260$6,068,934

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$54K$107K2015 Drug cost: $22,718 (USD; Tot_Drug_Cst)2016 Drug cost: $107,014 (USD; Tot_Drug_Cst)2017 Drug cost: $51,355 (USD; Tot_Drug_Cst)2018 Drug cost: $33,975 (USD; Tot_Drug_Cst)2019 Drug cost: $34,046 (USD; Tot_Drug_Cst)2020 Drug cost: $48,499 (USD; Tot_Drug_Cst)2021 Drug cost: $45,484 (USD; Tot_Drug_Cst)2022 Drug cost: $32,506 (USD; Tot_Drug_Cst)2023 Drug cost: $37,060 (USD; Tot_Drug_Cst)2024 Drug cost: $35,120 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015109301$22,718
2016133414$107,014
2017125415$51,355
2018144475$33,975
2019143467$34,046
2020133465$48,499
2021158514$45,484
2022115405$32,506
2023126433$37,060
2024167524$35,120

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg3133,424$654
67028Injection of drug into eye5812,407$109
92014Established patient complete exam of visual system9491,832$94
92134Imaging of retina1,0573,085$32
92250Photography of the retina198238$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium29960$11,447
Prednisolone AcetatePrednisolone Acetate1003,176$4,633
LatanoprostLatanoprost1076,429$1,256
MoxifloxacinMoxifloxacin Hcl49813$1,062
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol14601$935

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$265Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Benz, MD?

Tedicare shows public-source Medicare data for Matthew Benz, MD (NPI 1689771545), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Benz, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Benz, MD?

Matthew Benz, MD is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1902975352) in the available physician profile data.

Does Matthew Benz, MD have Open Payments data?

Matthew Benz, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.